| Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group F Rodeghiero, R Stasi, T Gernsheimer, M Michel, D Provan, DM Arnold, ... Blood, The Journal of the American Society of Hematology 113 (11), 2386-2393, 2009 | 3326 | 2009 |
| Tocilizumab in hospitalized patients with severe Covid-19 pneumonia IO Rosas, N Bräu, M Waters, RC Go, BD Hunter, S Bhagani, D Skiest, ... New England Journal of Medicine 384 (16), 1503-1516, 2021 | 1112* | 2021 |
| American Society of Hematology 2019 guidelines for immune thrombocytopenia C Neunert, DR Terrell, DM Arnold, G Buchanan, DB Cines, N Cooper, ... Blood advances 3 (23), 3829-3866, 2019 | 961 | 2019 |
| Updated international consensus report on the investigation and management of primary immune thrombocytopenia D Provan, DM Arnold, JB Bussel, BH Chong, N Cooper, T Gernsheimer, ... Blood advances 3 (22), 3780-3817, 2019 | 840 | 2019 |
| Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell–depleting therapy with rituximab R Stasi, N Cooper, G Del Poeta, E Stipa, M Laura Evangelista, ... Blood, The Journal of the American Society of Hematology 112 (4), 1147-1150, 2008 | 490 | 2008 |
| Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review R Stasi, A Sarpatwari, JB Segal, J Osborn, ML Evangelista, N Cooper, ... Blood, The Journal of the American Society of Hematology 113 (6), 1231-1240, 2009 | 475 | 2009 |
| Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ... Jama 326 (6), 499-518, 2021 | 470 | 2021 |
| The efficacy and safety of B‐cell depletion with anti‐CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura N Cooper, R Stasi, S Cunningham‐Rundles, MA Feuerstein, JP Leonard, ... British journal of haematology 125 (2), 232-239, 2004 | 450 | 2004 |
| Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia VL Patel, M Mahévas, SY Lee, R Stasi, S Cunningham-Rundles, ... Blood, The Journal of the American Society of Hematology 119 (25), 5989-5995, 2012 | 430 | 2012 |
| Comprehensive rare variant analysis via whole-genome sequencing to determine the molecular pathology of inherited retinal disease KJ Carss, G Arno, M Erwood, J Stephens, A Sanchis-Juan, S Hull, K Megy, ... The American Journal of Human Genetics 100 (1), 75-90, 2017 | 409 | 2017 |
| The pathogenesis of immune thrombocytopaenic purpura N Cooper, J Bussel British journal of haematology 133 (4), 364-374, 2006 | 399 | 2006 |
| Response to B-cell–depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura R Stasi, G Del Poeta, E Stipa, ML Evangelista, MM Trawinska, N Cooper, ... Blood, The Journal of the American Society of Hematology 110 (8), 2924-2930, 2007 | 395 | 2007 |
| Immune thrombocytopenia N Cooper, W Ghanima New England Journal of Medicine 381 (10), 945-955, 2019 | 357 | 2019 |
| Thrombopoietin receptor agonists: ten years later W Ghanima, N Cooper, F Rodeghiero, B Godeau, JB Bussel Haematologica 104 (6), 1112, 2019 | 279 | 2019 |
| Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura? M Michel, N Cooper, C Jean, C Frissora, JB Bussel Blood 103 (3), 890-896, 2004 | 278 | 2004 |
| Fostamatinib for the treatment of adult persistent and chronic immune thrombocytopenia: results of two phase 3, randomized, placebo‐controlled trials J Bussel, DM Arnold, E Grossbard, J Mayer, J Treliński, W Homenda, ... American journal of hematology 93 (7), 921-930, 2018 | 275 | 2018 |
| Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group F Rodeghiero, M Michel, T Gernsheimer, M Ruggeri, V Blanchette, ... Blood, The Journal of the American Society of Hematology 121 (14), 2596-2606, 2013 | 259 | 2013 |
| Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis N Cooper, K Rao, K Gilmour, L Hadad, S Adams, C Cale, G Davies, ... Blood 107 (3), 1233-1236, 2006 | 236 | 2006 |
| Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD A Khoder, A Sarvaria, A Alsuliman, C Chew, T Sekine, N Cooper, ... Blood, The Journal of the American Society of Hematology 124 (13), 2034-2045, 2014 | 227 | 2014 |
| Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans P Tuijnenburg, HL Allen, SO Burns, D Greene, MH Jansen, E Staples, ... Journal of allergy and clinical immunology 142 (4), 1285-1296, 2018 | 209 | 2018 |
